1-2 of 2
Giulio Superti-Furga, Ph.D.
Close
Sort by
Journal Articles

Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms

Klampfl Thorsten, Ph.D., Heinz Gisslinger, M.D., Ashot S Harutyunyan, M.D., Harini Nivarthi, Ph.D., Elisa Rumi, M.D., Jelena D. Milosevic, M.Sc., Nicole C.C. Them, M.Sc., Tiina Berg, B.Sc., Bettina Gisslinger, M.Sc., Daniela Pietra, Ph.D., Doris Chen, Ph.D., Gregory I. Vladimer, Ph.D., Klaudia Bagienski, M.Sc., Chiara Milanesi, M.Sc., Ilaria Carola Casetti, M.D., Emanuela Sant'Antonio, M.D., Virginia Ferretti, Ph.D., Chiara Elena, M.D., Fiorella Schischlik, M.Sc., Ciara Cleary, M.Sc., Melanie Six, B.Sc., Martin Schalling, M.Sc., Andreas Schönegger, M.Sc., Christoph Bock, Ph.D., Luca Malcovati, M.D., Christiana Pascutto, Ph.D., Giulio Superti-Furga, Ph.D., Mario Cazzola, M.D., Robert Kralovics, Ph.D.
Journal: Blood
Blood (2013) 122 (21): LBA-1.
https://doi.org/10.1182/blood.V122.21.LBA-1.LBA-1
Published: 2013
Journal Articles

Delineation of a KIT-Independent Oncogenic Pathway in Neoplastic Mast Cells That Involves Lyn and Btk, and Can Be Disrupted by the KIT/Lyn/Btk-Targeting Drug Dasatinib

Karoline V. Gleixner, MD, Matthias Mayerhofer, M.D., Uwe Rix, Ph.D., Gregor Hoermann, Alexander Gruze, Maria-Theresa Krauth, M.D., Winfried F. Pickl, M.D., Christian Sillaber, M.D., Giulio Superti-Furga, Ph.D., Peter Valent, M.D.
Journal: Blood
Blood (2007) 110 (11): 1541.
https://doi.org/10.1182/blood.V110.11.1541.1541
Published: 2007